Cod-THC

Cod-THC (Codeine Δ 9 -tetrahydrocannabinol carbonate) is a synthetic codrug formed by linking tetrahydrocannabinol with codeine via a carbonate bridge.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 4 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Pharmaceutical compound

Cod-THC (Codeine Δ9-tetrahydrocannabinol carbonate) is a synthetic codrug formed by linking tetrahydrocannabinol with codeine via a carbonate bridge. It is well absorbed orally and shows superior analgesic effects in animal studies compared to a simple mixture of the two drugs.[1][2][3]

THC can partially inhibit CYP2D6, which is the enzyme that transforms codeine into its active metabolite morphine.[4][5] It's not well understood how THC may impact codeines metabolism in humans.

See also

edit edit source

References

edit edit source
  1. ^ Banerjee A, Hayward JJ, Trant JF (May 2023). ""Breaking bud": the effect of direct chemical modifications of phytocannabinoids on their bioavailability, physiological effects, and therapeutic potential". Organic & Biomolecular Chemistry. 21 (18): 3715–3732. doi:10.1039/d3ob00068k. PMID 36825573. Wikipedia revision 1346557661, retrieved 2026-11-20
  2. ^ US 2008176885A1, Holtman JR, Crooks PA, Dhooper HK, "Novel synergistic opioid-cannabinoid codrug for pain management", published 24 July 2008, assigned to University of Kentucky and Insys Therapeutics Inc  Wikipedia revision 1346557661, retrieved 2026-11-20
  3. ^ Crooks PA, Dhooper HK, Chakraborty U (2010). "Improving the Use of Drug Combinations Through the Codrug Approach". Prodrugs and Targeted Delivery. Methods and Principles in Medicinal Chemistry. Vol. 47. pp. 345–383. doi:10.1002/9783527633166.ch13. ISBN 978-3-527-32603-7. Wikipedia revision 1346557661, retrieved 2026-11-20
  4. ^ Nasrin S, Watson CJ, Perez-Paramo YX, Lazarus P (December 2021). "Cannabinoid Metabolites as Inhibitors of Major Hepatic CYP450 Enzymes, with Implications for Cannabis-Drug Interactions". Drug Metabolism and Disposition. 49 (12): 1070–1080. doi:10.1124/dmd.121.000442. PMC 11022895. PMID 34493602. Wikipedia revision 1346557661, retrieved 2026-11-20
  5. ^ Huff HC, Vasan A, Roy P, Kaul A, Tajkhorshid E, Das A (September 2021). "Differential Interactions of Selected Phytocannabinoids with Human CYP2D6 Polymorphisms". Biochemistry. 60 (37): 2749–2760. doi:10.1021/acs.biochem.1c00158. PMC 8455456. PMID 34491040. Wikipedia revision 1346557661, retrieved 2026-11-20
CannabinoidsPhytocannabinoids
(comparison) Endocannabinoids Synthetic
cannabinoid
receptor
agonists /
neocannabinoids
Allosteric CBRTooltip Cannabinoid receptor ligands Endocannabinoid
enhancers

(inactivation inhibitors) Anticannabinoids
(antagonists/inverse
agonists/antibodies)

Text derived from https://en.wikipedia.org/w/index.php?oldid=1346557661 under CC BY-SA 4.0; modifications have been made.